Solórzano-Vázquez JF, Hernández- Higareda S, Segura-Zavala JM, Oseguera-Torres LF, de la Rosa-Hernández S

Language: Spanish
References: 17
Page: 491-497
PDF size: 303.45 Kb.

ABSTRACT

Background: Placenta accreta (abnormal insertion of the placenta or part of the myometrium ) endangers the lives of pregnant women. It is a public health problem because it can be complicated by obstetric hemorrhage , the latter being the main cause of maternal death worldwide.
Objetive: To estimate the blood loss and the use of blood products in patients who underwent cesarean - hysterectomy for placenta accreta .
Material and Method: A descriptive study was conducted in HGO UMAE CMNO IMSS in patients who underwent cesarean - hysterectomy for placenta accreta in a period of 4 years.
Results: 106 cases of placenta accreta were studied, 23% had a massive bleeding of › 3000 cc. Packed red blood cells were transfused in 68% of events, fresh frozen plasma in platelet concentrates 29% and 6%. The history of uterine curettage was observed in 64 % and cesarean section 1 or 2 occasions in 76 % of cases.
Conclusion: An early detection of placenta accreta in patients with risk factors to avoid emergency surgery is desired. Being prepared with blood products and appropriate use is a cornerstone in the management of this condition. The average blood loss was determined in cases of accreta in cesarean hysterectomy was 2523 milliliters.

REFERENCES

1. Oyelese Y, Smulian JC. Placenta previa, placenta accreta, and vasa previa. Obstet Gynecol 2006;107(4):927-941.

2. Belfort MA. Placenta accreta. Am J Obst Gyn 2010;203:230-239.

3. Dueñas O, Rico H. Actualidad en el diagnóstico y manejo de acretismo placentario. Rev Chil Obstet Ginecol 2007;72:266-271.

4. Wu S, Kocherginsky M, Hibbard JU. Abnormal placentation: twenty-year analysis. Am J Obstet Gynecol 2005;192:1458- 1461.

5. Lira J, Ibarbuengoitia F, Argueta M, Karchmer S. Placenta previa/acreta y cesárea previa. Experiencia de cinco años en el Instituto Nacional de Perinatología. Ginecol Obstet Mex 1995;63(8):337-340

6. Miller DA, Chollet JA, Goodwin TM. Clinical risk factors for placenta previa-placenta accreta. Am J Obstet Gynecol 1997;177:210-214.

7. Silver RM, Landon MB, Rouse DJ, Leveno KJ, Spong CY, Thom EA, et al. Maternal Morbidity associated with multiple repeat cesarean deliveries. National Institute Child Health and Human Development Maternal-Fetal Medicine Units Network. Obstet Gynecol 2006;107:1226-1232.

8. Pri-Paz S, Abellar M, Li B, Zerlin-Esteves M, Devine P, Kitajewsky J, Wright J. Role of hipoxic pathways in the development of placenta accreta. Am J Obstet Gynecol 2012;206(1):S35-S36.

9. Bernischke K, Kaufmann P. Placental shape aberrations. In: Benirschke K, Kaufmann P (eds). Pathology of the human placenta. 4th ed. New York: Springer, 2000;399-418.

10. Green-top Guideline 27. Placenta previa, placenta accreta and vasa previa: diagnosis and management. Royal College of Obstetricians and Gynaecologists. [en línea]. Dirección URL: .

11. Parra G, Diaz I, Montes S, et al. Acretismo placentario, diagnóstico prenatal mediante ultrasonido y resonancia magnética y su correlación histopatológica en Barranquilla (Colombia). Rev Colom Obst Ginecol 2009;3:281-285.

12. Crum C. Tracto genital femenino. In: Cotran R, Kumar V, Collins T. 1ª ed. Patologia estructural y funcional. Mexico: Mc Graw-Hill Interamericana, 2009;1063-1099.

13. Eller A, Porter T, Soisson P, Silver R. Optimal management strategies for placenta accreta. BJOG 2009;116:648-654.

14. Revelez J, Villegas G, Hernadez S, et al. Histerectomía obstétrica: incidencia, indicaciones y complicaciones. Ginecol Obstet Mex 2008;76(3):156-160.

15. Allahdin S, Voigt S, Htwe T. Management of placenta praevia and accreta. Jou Obstet Gynaec.2011;31(1):1-6.

16. Pacheco L, Gei A. Controversies in management of placenta accrete. Obstet Gynecol Clin N Am 2011;38:313-322.

17. Bretelle F, Courbiere B, Mazouni C, et al. Management of placenta accreta: Morbidity and outcome. Europ J Obst Gynecol Rep Bio 2007;133:34-39.